Back to Neurology


Alzheimer's Disease (AD)

Alzheimer's Disease Market Research

What is Alzheimer’s Disease (AD)?

Alzheimer’s disease (AD) is the most common cause of dementia, a brain disorder that gets worse over time. It is characterized by changes in the brain, such as the accumulation of amyloid plaques, causing brain cells to die. Alzheimer’s disease causes a gradual decline in memory, thinking, behavior and social skills. Currently, treatments are focused on maintaining mental functions and managing the behavioral aspects of day-to-day life.

Spherix Global Insights – Neurology – Alzheimer’s Disease (AD)

Spherix’s Neurology team covers the Alzheimer’s disease (AD) market in our Market Dynamix™, Launch Dynamix™ and Special Topix™ services. Spherix’s has the following studies publishing this year covering AD:

  • Market Dynamix™: Early Alzheimer’s Disease (US)
  • Launch Dynamix™: Leqembi (Eisai/Biogen) in Alzheimer’s Disease (US)
  • Launch Dynamix™: Donanemab (Eli Lilly) in Alzheimer’s Disease (US)*
  • Special Topix™: Accelerated Approvals in Early Alzheimer’s Disease (Leqembi)

*Pending approvals and launch

Spherix’s Market Dynamix™ service is an independent service providing analysis of markets anticipated to experience a paradigm shift within the next three to five years. Insights highlight market size, current treatment approaches, unmet needs, and expert opinions on the likely disruption introduced by pipeline agents.

Spherix’s Launch Dynamix™ service consists of two parts: monthly KPI tracking and quarterly deep dives. Monthly KPIs provide benchmarking of newly launched products for the first eighteen months of commercial availability, and quarterly deep dive reports includes promotional activity, barriers to uptake, and patient types gravitating to the launch brand.

Spherix’s Special Topix™ service is an independent service that includes access to a report or series of reports based on current events or topics of interest in specialty markets covered by Spherix.

Follow Spherix Neurology on Social Media

Follow us for neurology industry news, insights & analysis:


For Guests & Current Clients

For more details on Spherix’s primary market research reports and interactive dashboard offerings, visit or register here:


Get more information on Spherix's Alzheimer's Disease Coverage